Analysis examines Direct Meds GLP-1 medications platform as LegitScript-certified telehealth option for compounded semaglutide and tirzepatide access....
Core Laboratories (NYSE:CLB – Get Free Report) updated its first quarter 2026 earnings guidance on Thursday. The company provided EPS guidance of 0.050-0.070 for the period, compared to the consensus EPS estimate of 0.160. The company issued revenue guidance of $119.0 million-$123.0 million, compared
CSL shares have tumbled again. The post CSL shares: 3 reasons to buy and 3 reasons to sell appeared first on The Motley Fool Australia . Read Full Article →
The House Labor Committee voted to kill a bill that would have established a state minimum wage starting at $12. Read Full Article →
The U.S. Postal Service has decided to temporarily suspend its contributions to Federal Employees Retirement System annuities. This move is aimed at preserving cash and liquidity amid a severe financial crisis. Officials warn the USPS could run out of cash... Read Full Article →
